Korsana Biosciences, Inc. (KRSA)
NASDAQ: KRSA · Real-Time Price · USD
27.97
+3.41 (13.88%)
Sep 11, 2026, 10:19 AM EDT - Market open
Korsana Biosciences Market Cap
Korsana Biosciences has a market cap or net worth of $18.71 million as of September 11, 2026. Its market cap has increased by 123.08% in one year.
Market Cap
18.71M
Enterprise Value
n/a
1-Year Change
123.08%
Ranking
n/a
Category
Stock Price
$27.97
ChartMarket Cap Chart
Since September 13, 2021, Korsana Biosciences's market cap has decreased from $133.34M to $18.71M, a decrease of -85.97%. That is a compound annual growth rate of -32.51%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 10, 2026 | 14.91M | 264.16% |
| Dec 31, 2025 | 4.10M | -50.24% |
| Dec 31, 2024 | 8.23M | -0.70% |
| Dec 29, 2023 | 8.29M | -70.97% |
| Dec 30, 2022 | 28.55M | -59.84% |
| Dec 31, 2021 | 71.09M | -46.68% |
| Sep 13, 2021 | 133.34M | - |
View and export this data all the way back to 2021. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 1.00T |
| Johnson & Johnson | 641.88B |
| AbbVie | 450.61B |
| Merck & Co. | 357.02B |
| Concord Medical Services Holdings | 17.15M |
| Enlivex | 17.15M |
| BioCardia | 16.65M |
| Moleculin Biotech | 16.16M |